Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Switzerland Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20111
20133
20152
20163
20174
20192
20214
20234
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting7
Terminated7
Active, not recruiting4
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
University Hospital, Basel, Switzerland3
Akero Therapeutics, Inc2
University of Zurich2
Astellas Pharma Inc1
BAR Pharmaceuticals s.r.l.1
Bristol-Myers Squibb1
Eli Lilly and Company1
Fondazione Epatocentro Ticino1
Genfit1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease30
Liver Cirrhosis5
Obesity5
Fatty Liver4
Fibrosis4
Liver Diseases3
Carcinoma, Hepatocellular1
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Digestive System Diseases1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.